Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CCEP✓SelectedUSD · CCEPMRNA vs CCEP performance historyLatest closeAs of+1.29%11/19
Stock and ETF performance explorer

MRNA vs CCEP

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+971.7%
CCEP return
+201.2%
Excess return
+770.5%
Maximum drawdown
-95.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCCEPExcessAlpha
1D+1.3%-2.2%+3.5%+1.6%
7D-13.8%-0.6%-13.3%-13.8%
30D-17.7%+2.5%-20.2%-18.0%
3M+14.3%+9.0%+5.3%+12.8%
6M+336.0%+26.6%+309.4%+319.3%
YTD+575.9%+29.6%+546.4%+548.4%
1Y+724.4%+31.4%+693.0%+689.0%
3Y+160.8%+106.4%+54.3%+132.5%
5Y-24.4%+155.7%-180.1%-35.2%
All+971.7%+201.2%+770.5%+764.5%

Cumulative growth

Daily Returns

Daily percentage return beside CCEP.

Daily Out/Under-Performance

Portfolio return minus CCEP return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CCEP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded CCEP wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling